Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20146631 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.
Conditions: HIV;   HIV-1;   Human Immunodeficiency Virus
Intervention: Drug: GS-9137 - A Novel HIV-1 Integrase Inhibitor

Indicates status has not been verified in more than two years